Program

The program covers updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics as well as in other European countries and beyond.

Program details will be available soon. Already confirmed speakers are listed under "Speakers".

September 17-19, 2023
Oslo, Norway

Sunday

September 17

19.00 - 21.30

Get together

Monday

September 18

09.00 - 09.45

Keynote Speaker David Thomas, Garvan Institute of Medical Research, Australia
Omico: Australia's Genomic Cancer Medicine Centre

Session 1: Molecular Pathology & MTBs

09.45 - 10.15

Funda Meric-Bernstam, MD Anderson Cancer Centre, USA

Title: TBA
10.15 - 10.30

Short Abstract Talk TBC (10 + 5 min)

Title
10.30 - 11.00

Maud Kamal, Institut Curie, Paris

Molecular tumor boards & treatment algorithms in Oncology: Institut Curie Experience
11.00 - 11.15

Short Abstract Talk TBC (10 + 5 min)

Title
11.15 - 11.45

Lynette Sholl, Dana-Farber / Harvard Cancer Center, USA

Integrated tumor and germline profiling for cancer patients: challenges and benefits
12.00 - 13.00

Lunch

13.00 - 15.00

Poster Session

Session 2: Clinical  Study Designs

15.00 - 15.30

Christophe Le Tourneau, Institut Curie, Paris

Precision medicine trials in oncology
15.30 - 15.45

Short Abstract Talk TBC (10 + 5 min)

15.45 - 16.15

Emile Voest, NCI, The Netherlands

Title: TBA
16.15 - 16.30

Short Abstract Talk TBC (10 + 5 min)

Title
16.30 - 17.00

Richard Schilsky, University of Chicago, USA

The ASCO TAPUR Study: Learning from precision medicine in practice 
19.00

Aperitif in the reception area

19.45

Dinner

Tuesday

September 19

08.30 - 09.15

Keynote Speaker Gordon Mills, Knight Cancer Institute, OHSU, USA:
Targeting adaptive responses in cancer through SMMART clinical trials

Session 3: Health Economics, Implementation & Policies

09.15 - 09.45

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, CZ Health Insurance, The Netherlands

Keeping pace with advances in Precision Medicine: a payer's perspective
09.45 - 10.00

Short Abstract Talk TBC (10 + 5 min)

Title
10.00 - 10.30

Bettina Ryll, Stockholm School of Economics, Sweden

Title: TBA
10.30 - 10.45

Short Abstract Talk TBC (10 + 5 min)

Title
10.45 - 11.15

Monika Frenzel, French National Research Agency

The personalized medicine journey
11.30 - 12.30

Lunch

Session 4: Scaling of Precision Medicine Ecosystems

12.30 - 13.00

Jesus Garcia-Foncillas, Jiménez Diaz Foundation University Hospital, Madrid, Spain

Title: TBA
13.00 - 13.15

Short Abstract Talk TBC (10 + 5 min)

Title
13.15 - 13.45

Benedikt Westphalen, LMU Munich, Germany

Sustainable scaling of precision oncology - in or out of reach?
13.45 - 14.00

Short Abstract Talk TBC (10 + 5 min)

Title
14.00 - 14-30

Christopher McCabe, Queen's University Belfast, Northern Ireland, UK

With scale comes risk: how should payers respond?
14.30 - 14.55

Coffee Break

Session 5: DRUP-like Trials

15.00 - 15.25

Hans Gelderblom, Leiden University Medical Centre, The Netherlands

The DRUP Trial
15.25 - 15.40

Åslaug Helland, Oslo University Hospital, Oslo, Norway

The IMPRESS-Norway Trial
15.40 - 15.55

Ulrik Lassen, Rigshospitalet, Copenhagen, Denmark

The ProTarget Trial
15.55 - 16.10

Katriina Peltola, Helsinki University Hospital, Finland

The FINPROVE Trial
16.10 - 16.25

Loic Verlingue, Centre Léon Bérard, Lyon, France

The MOSTPlus Trial
16.25 - 16.40

Matthew Krebs, University of Manchester, UK

The DETERMINE Trial
16.40 - 16.55

Maeve Lowery, Trinity College Dublin and St James Hospital, Ireland

The PROGRESS Trial
17.00 - 17.10

Concluding Remarks

Nordic Precision Cancer Medicine

An Acta Oncologica Conference

The overarching theme of this two-day conference is precision cancer medicine. Internationally renowned speakers will give scientific updates as well as updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics and other European countries. Furthermore, patient benefit and visions for the future, including standard health care, is on the agenda.